Trial of 70% Ethanol Versus Heparin to Reduce the Rate of Central Line Infections in Children With Short Bowel Syndrome
NCT01263574 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2017-06-22
Summary
This study is designed to determine if the use of 70% ethanol lock solution in central lines decreases the rate of central line infections in children with short bowel syndrome. While ethanol locks have been used safely in children, there has been no published research to date that clearly shows it is of definite benefit in this group of patients.
Conditions
- Catheter Related Infections
- Short Bowel Syndrome
Interventions
- DRUG
-
70% ethanol
Administration of the lock solution will occur between cycles of parenteral nutrition. Lock solutions will be administered three days per week. The pre-measured volume of lock solution will then be injected into the catheter for 4 hours. Prior to the next instillation of medications into the catheter, the lock solution will be aspirated and discarded. Another 5mL flush of saline will then be instilled into the catheter prior to medication or parenteral nutrition administration. Volume of lock solution administered will be determined by catheter size.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Tom Jaksic, M.D, Ph.D · Boston Children's Hospital
-
Christopher Duggan, M.D, MPH · Boston Children's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 3 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2012-06-30
- Completion
- 2012-09-30
Countries
- United States
Study Locations
More Related Trials
-
Pilot Study of NASHA/Dx Gel for Fecal Incontinence
NCT00971269 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral Nutrition
NCT02682381 ·Status: COMPLETED ·Phase: PHASE3
-
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
NCT01075789 ·Status: TERMINATED ·Phase: NA
-
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NCT03530852 ·Status: RECRUITING ·Phase: NA
-
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
NCT05535361 ·Status: RECRUITING ·Phase: NA
-
Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal Arterial Ischemic Stroke
NCT02460484 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel Syndrome
NCT03571516 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous (IV) Solutions for Dehydration in Children With Gastroenteritis
NCT01234883 ·Status: TERMINATED ·Phase: PHASE4
-
Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
NCT03043430 ·Status: TERMINATED ·Phase: PHASE4
-
Safety During Use of Paediatric Triple Chamber Bag Formulas
NCT01304394 ·Status: COMPLETED ·Phase: PHASE3
-
Acceptability of Various Available Midazolam Formulations (Syrup, Rectal Suppository, Oro-dispersible Minitablet) in Clinical Practice
NCT05894057 ·Status: RECRUITING
-
A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome
NCT01952080 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Autism
NCT05003960 ·Status: RECRUITING ·Phase: PHASE1
-
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
NCT01495793 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
NCT00081458 ·Status: COMPLETED ·Phase: PHASE3
-
Nutritional Tolerance and Safety of a Tube Feeding Formula
NCT05848583 ·Status: TERMINATED ·Phase: NA
-
Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial
NCT05327556 ·Status: TERMINATED ·Phase: PHASE2
-
IV Glucose for Dehydration Treatment
NCT01285713 ·Status: COMPLETED ·Phase: PHASE2
-
Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis.
NCT06048614 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)
NCT00172185 ·Status: COMPLETED ·Phase: PHASE3
-
Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study
NCT02044159 ·Status: COMPLETED ·Phase: PHASE4
-
A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence
NCT00605826 ·Status: COMPLETED ·Phase: NA
-
Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome
NCT03419156 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Pediatric Procedural Sedation With Rectal Chloral Hydrate or Intranasal Midazolam
NCT01402596 ·Status: WITHDRAWN ·Phase: PHASE2
-
Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends
NCT07341464 ·Status: RECRUITING ·Phase: NA